Curis
CRIS
#10201
Rank
โ‚น1.56 B
Marketcap
โ‚น121.28
Share price
0.00%
Change (1 day)
-63.74%
Change (1 year)

Curis (CRIS) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น0.81 Billion

According to Curis's latest financial reports the company has โ‚น0.81 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Curis - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น1.71 B-63.42%
2023-12-31โ‚น4.68 B-33.81%
2022-12-31โ‚น7.08 B-17.86%
2021-12-31โ‚น8.62 B-30%
2020-12-31โ‚น12.32 B741.17%
2019-12-31โ‚น1.46 B-13.68%
2018-12-31โ‚น1.69 B-55.87%
2017-12-31โ‚น3.84 B27.22%
2016-12-31โ‚น3.02 B-44.65%
2015-12-31โ‚น5.46 B73.23%
2014-12-31โ‚น3.15 B-12.28%
2013-12-31โ‚น3.59 B18.2%
2012-12-31โ‚น3.04 B52.41%
2011-12-31โ‚น1.99 B9.67%
2010-12-31โ‚น1.81 B55.27%
2009-12-31โ‚น1.17 B-15.52%
2008-12-31โ‚น1.38 B-14.77%
2007-12-31โ‚น1.62 B0.22%
2006-12-31โ‚น1.62 B-18.39%
2005-12-31โ‚น1.98 B-7.23%
2004-12-31โ‚น2.14 B33.27%
2003-12-31โ‚น1.60 B-18.12%
2002-12-31โ‚น1.96 B-21.85%
2001-12-31โ‚น2.51 B-28.24%
2000-12-31โ‚น3.50 B277.12%
1999-12-31โ‚น0.92 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Exelixis
EXEL
โ‚น88.80 B 10,821.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น22.05 B 2,612.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚น5.04 B 520.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น52.39 B 6,343.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.346 T 165,450.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.482 T 182,222.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น0.16 B-80.19%๐Ÿ‡บ๐Ÿ‡ธ USA